IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 79
Titolo Data di pubblicazione Autore(i) File
Expression of HLA-class II antigens and proliferative capacity in autologous mixed lymphocyte reactions of human T lymphocytes exposed in vitro to alpha-endorphin. 1-gen-1989 Morgano, A; Setti, M; Pierri, Ivana; Barabino, A; Lotti, G; Indiveri, F.
New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting. 1-gen-1990 Scudeletti, M; Castagnetta, L; Imbimbo, B; Puppo, Francesco; Pierri, Ivana; Indiveri, F.
Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans. 1-gen-1990 Morgano, A; Pierri, Ivana; Stagnaro, R; Setti, M; Puppo, Francesco; Indiveri, F.
[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)]. 1-gen-1991 Gobbi, Marco; Michieli, M; Raspadori, D; Damiani, D; Michelutti, A; Pierri, Ivana; Tazzari, Pl
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 1-gen-1993 Miglino, Maurizio; Pierri, Ivana; Canepa, L; Carrara, P; Celesti, L; Gobbi, Marco
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 1-gen-1994 Spriano, M; Clavio, M; Carrara, P; Canepa, L; Miglino, Maurizio; Pierri, Ivana; Celesti, L; Rossi, E; Vimercati, R; Bruni, R; Santini, G; Gatti, Am; Stura, P; Ghio, Riccardo; Patrone, Franco; Damasio, E; Gobbi, Marco
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. 1-gen-1995 Tazzari, Pl; Ricci, F; Vianelli, N; Tassi, C; Belletti, D; Pierri, Ivana; Gugliotta, L; Gobbi, Marco; Conte, R.
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 1-gen-1996 Clavio, M; Carrara, P; Miglino, Maurizio; Pierri, Ivana; Canepa, L; Balleari, E; Gatti, Am; Cerri, R; Celesti, L; Vallebella, E; Sessarego, Mario; Patrone, Franco; Ghio, Riccardo; Damasio, E; Gobbi, Marco
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly. 1-gen-1999 Pierri, Ivana; Clavio, M; Beltrami, G; Cavaliere, M; Lanza, L; Miglino, Maurizio; Canepa, L; Pietrasanta, D; Ballerini, F; Quintino, S; Gatto, S; Celesti, L; Carrara, P; Varese, P; Gobbi, Marco
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly. 1-gen-1999 Pierri, Ivana; Clavio, M; Miglino, Maurizio; Cavaliere, M; Pietrasanta, D; Gobbi, Marco
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method. 1-gen-2001 Miglino, Maurizio; Grasso, R; Pietrasanta, D; Palmisano, Gl; Berisso, G; Clavio, M; Pierri, Ivana; Santini, G; Canepa, L; Gobbi, Marco
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells 1-gen-2001 Zocchi, M. R.; Pellegatta, F.; Pierri, Ivana; Gobbi, Marco; Poggi, A.
Thalidomide in agnogenic and secondary myelofibrosis 1-gen-2001 Canepa, L.; Ballerini, F.; Varaldo, R.; Quintino, S.; Reni, L.; Clavio, M.; Miglino, Maurizio; Pierri, Ivana; Gobbi, Marco
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 1-gen-2001 Clavio, M.; Gatto, S.; Beltrami, G.; Cerri, R.; Gobbi, Marco; Pierri, Ivana; Canepa, L.; Miglino, Maurizio; Sessarego, Mario; Gobbi, Marco
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? 1-gen-2001 Clavio, M.; Quintino, S.; Venturino, C.; Ballerini, F.; Varaldo, R.; Gatto, S.; Galbusera, V.; Garrone, A.; Grasso, R.; Canepa, L.; Miglino, Maurizio; Pierri, Ivana; Gobbi, Marco
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. 1-gen-2001 Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, Ivana; Canepa, L; Miglino, Maurizio; Muner, P; Damasio, E; Gobbi, Marco
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin’s lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation 1-gen-2001 Miglino, Maurizio; Santini, G.; Grasso, R.; Pietrasanta, D.; Clavio, M.; Pierri, Ivana; Canepa, L.; Nati, S.; Ballerini, F.; Varaldo, R.; Palmisano, G.; Gobbi, Marco
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 1-gen-2002 M., Clavio; S., Gatto; G., Beltrami; S., Quintino; L., Canepa; Pierri, Ivana; V., Galbusera; P., Carrara; Miglino, Maurizio; R., Varaldo; F., Ballerini; C., Venturino; R., Cerri; M., Risso; E., Balleari; A. M., Carella; Sessarego, Mario; Ghio, Riccardo; A., Bacigalupo; Gobbi, Marco
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia 1-gen-2002 Russo, D; Piccaluga, Pp; Michieli, M; Michelutti, T; Visani, G; Gugliotta, L; Bonini, A; Pierri, Ivana; Gobbi, Marco; Tiribelli, M; Fanin, R; Piccolrovazzi, S; Baccarani, M.
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 1-gen-2002 Miglino, Maurizio; Berisso, G; Grasso, R; Canepa, L; Verdiani, Simonetta; Clavio, M; Pierri, Ivana; Pietrasanta, D; Gatto, S; Varaldo, R; Ballerini, F; Verdiani, S; Casarino, L; Destefano, F; Sessarego, Mario; Dominietto, A; Raiola, Am; Bregante, S; DI GRAZIA, C; Gobbi, Marco; Bacigalupo, A.
Mostrati risultati da 21 a 40 di 79
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile